Changes of PTH, 1,25(OH)2D3 and Biochemistry in Renal Osteodystrophy.

被引:0
|
作者
Jia Jing-kang
33(1):33.
机构
关键词
Changes of PTH; OH; and Biochemistry in Renal Osteodystrophy; HTO; LTO;
D O I
暂无
中图分类号
R681 [骨骼疾病];
学科分类号
1002 ; 100210 ;
摘要
The changes of plasma PTH, 1,25(OH)D, serum calcium, phosphorus and AKP were observed in 55 uremic patients with renal osteodystrophy. The results showed that: in all types of renal osteodystrophy, plasma PTH were markedly higher than normal (P<0.001), while plasma 1,25(OHH)Dand serum calcium were lower than normal (P<0.001). In low bone-turnover uremic osteodystrophy (LTO), plasma phosphorus was markedly lower than that of high bone-turnover uremic osteodystrophy (HTO) and mixe d uremic osteodystrophy (MO) (P<0.05), and plasma 1,25(OH)Dwas significantly lower than that of HTO (P<0.05). In HTO and MO, serum phosphorus was much higher than mormal (P<0.001). Plasma PTH had a negative linear correlation with plasma 1,25(OH)D(P<0.05), a positive linear correlation with serum AKP (P<0.05), but no linear correlation with the duration of hemodialysis, serum calcium, serum aluminum and bone aluminum content. Plasma 1.25(OH)Dhad no linear correlation with the duration of hemodialysis, seru
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [31] 1,25(OH)2D3 - A NOVEL IMMUNOREGULATOR
    MANOLAGAS, SC
    TSOUKAS, CD
    PROVVEDINI, DM
    DEFTOS, LJ
    CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (04) : 519 - 519
  • [32] FORSKOLIN INCREASES RENAL 1,25(OH)2D3 PRODUCTION AND DECREASES 24,25(OH)2D3 PRODUCTION INVITRO
    ARMBRECHT, HJ
    FORTE, LR
    WONGSURAWAT, N
    ZENSER, TV
    DAVIS, BB
    CLINICAL RESEARCH, 1983, 31 (02): : A380 - A380
  • [33] 1,25(OH)2D3 ACTIVITY ON HEMATOPOIESIS
    PETRINI, M
    VAGLINI, F
    GRASSI, B
    AMBROGI, F
    HAEMATOLOGICA, 1989, 74 (02) : 227 - 228
  • [34] 24,25(OH)2D3 ATTENUATES THE CALCEMIC EFFECT OF 1,25(OH)2D3 IN RATS WITH REDUCED RENAL MASS
    RUBINGER, D
    COJOCARU, T
    POPOVTZER, MM
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1987, 186 (01): : 64 - 69
  • [35] RENAL HANDLING OF CALCIUM IN RATS - INFLUENCE OF PARATHYROID-HORMONE (PTH) AND 1,25-DIHYDROXYVITAMIN D3 (1,25(OH)2D3)
    HUGI, K
    FLEISCH, H
    BONJOUR, JP
    KIDNEY INTERNATIONAL, 1977, 12 (01) : 75 - 75
  • [36] Levels of 1,25(OH)2D3 for patients with pulmonary tuberculosis and correlations of 1,25(OH)2D3 with the clinical features of TB
    Gao, Wei-Wei
    Wang, Yu
    Zhang, Xiang-Rong
    Yin, Chun-Yang
    Hu, Chun-Mei
    Tian, Man
    Wang, Hong-Wei
    Zhang, Xia
    JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : 760 - 764
  • [37] INCREASED CLEARANCE OF 1,25(OH)2D3 AND TISSUE-SPECIFIC RESPONSIVENESS TO 1,25(OH)2D3 IN DIABETIC RATS
    VERHAEGHE, J
    SUIKER, AMH
    VANBREE, R
    VANHERCK, E
    JANS, I
    VISSER, WJ
    THOMASSET, M
    ALLEWAERT, K
    BOUILLON, R
    AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (02): : E215 - E223
  • [38] THE EFFECT OF 25(OH)D3 ON THE PRODUCTION OF 1,25(OH)2D3 IN CHRONIC-RENAL-FAILURE
    DUSSO, A
    LOPEZHILKER, S
    SLATOPOLSKY, E
    KIDNEY INTERNATIONAL, 1987, 31 (01) : 345 - 345
  • [39] EFFECT OF 1,25(OH)2D3 AND 24,25(OH)2D3 ON CALCIUM FLUXES INVITRO
    SCHWARTZ, Z
    LANGSTON, GG
    BOYAN, BD
    JOURNAL OF DENTAL RESEARCH, 1989, 68 (04) : 657 - 657
  • [40] HORMONAL RESPONSES TO 1,25(OH)2D3 ARE MODULATED BY CELL PROLIFERATION-DEPENDENT CHANGES IN 1,25(OH)2D3 RECEPTOR LEVELS DURING CULTURE
    CHEN, TL
    LI, JM
    VANYE, T
    CONE, CM
    FELDMAN, D
    CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (04) : 456 - 456